Status:
UNKNOWN
Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study
Lead Sponsor:
Hospital Sultanah Bahiyah
Collaborating Sponsors:
Hospital Tuanku Fauziah, Kangar, Perlis
Penang Hospital, Malaysia
Conditions:
SARS-CoV Infection
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The Malaysian COVID-19 Anosmia Study is a nationwide multicentre observational study to investigate the prevalence and characteristics of olfactory and gustatory/taste disturbances in COVID-19 infecti...
Detailed Description
The world is currently in the midst of the Coronavirus 2019 (COVID-19) pandemic that is caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). According to publis...
Eligibility Criteria
Inclusion
- Age at least 18 years old
- For Cases: Laboratory confirmed COVID-19 infection \[Reverse Transcription Polymerase Chain Reaction (RT-PCR)\]
- Patients clinically able to answer the questionnaire
Exclusion
- Patients with olfactory or taste/gustatory disorders before the COVID-19 epidemic
- For Cases: Patients without a laboratory-confirmed COVID-19 diagnosis
- For Cases: Patients in intensive care unit at the time of study
Key Trial Info
Start Date :
June 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04384042
Start Date
June 6 2020
End Date
March 31 2021
Last Update
February 25 2021
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Enche' Besar Hajjah Khalsom
Kluang, Johor, Malaysia, 86000
2
Hospital Sultanah Bahiyah
Alor Star, Kedah, Malaysia, 05400
3
Hospital Raja Perempuan Zainab II
Kota Bharu, Kelantan, Malaysia, 15200
4
Hospital Tuanku Jaafar
Seremban, Negeri Sembilan, Malaysia, 70300